Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast
- 15 June 1982
- Vol. 49 (12), 2534-2536
- https://doi.org/10.1002/1097-0142(19820615)49:12<2534::aid-cncr2820491221>3.0.co;2-j
Abstract
Tissue specimens from 27 patients with mammary fibrocystic disease were assayed for estrogen (ER) and progestin (PR) receptors. Seventeen patients (63%) had ER‐positive lesions (>5 fmol/mg protein). A progression in ER presence was noted from fibrocystic disease (33%) and fibrosing adenosis (50%) to lobular and ductal hyperplasia (85%). Similarly, ER content increased from 14.5 ± 13 fmol/mg cytosol protein in fibrocystic disease and fibrosing adenosis to 31.5 ± 23 fmol/mg protein in epithelial hyperplastic lesions. Furthermore, the ER‐PR couple was only encountered in lobular and ductal hyperplasia. The authors' data indicate that the incidence of steroid receptor parallels the intensity of hyperplasia in benign breast disease.This publication has 8 references indexed in Scilit:
- Estrogen receptor values in patients with benign breast diseaseCancer, 1979
- Multiple steroid receptors in human breast cancerCancer Chemotherapy and Pharmacology, 1979
- Multiple steroid receptors in human breast cancerCancer Chemotherapy and Pharmacology, 1979
- Studies on clinical, hormonal and pathological correlations in breast fibroadenomasThe Journal of Steroid Biochemistry and Molecular Biology, 1978
- Intraductal papillary tumors of the breast.A study of 78 casesCancer, 1977
- On the Origin and Progression of Ductal Carcinoma in the Human Breast2JNCI Journal of the National Cancer Institute, 1973
- Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancerCancer, 1972
- Early phases in the development of breast cancerCancer, 1969